Has Emily Newsom, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,717 in general payments to Emily Newsom, MD across 10 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emily Newsom, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emily Newsom, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emily Newsom, MD

MOHS-Micrographic Surgery · Valencia, CANPI 1639460744

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,375 of the $3,717 with a category attached, or 63.9%. E.r. Squibb & Sons, L.L.C. accounts for 90.5% of it on its own, with 2 other manufacturers making up the rest.

$3,717in general payments, 2019–2025

Across 10 payments — averaging $371.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$3K
Ortho Dermatologics, A Division Of Bausch Health US, LLC$202
AbbVie$150

What the payments were for

Consulting fees$2,37564%
Travel & lodging$86923%
Food & beverage$47313%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	7	$3,365
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$202
AbbVie	1	$150

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,717 in reported general payments places this provider in the 60th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California →

Medicare billing

Part B allowed, 2024

$277,802

Medicare patients

322

Services billed

959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	34	$129,492
OtezlaApremilast	11	$61,474
Fluocinonide	14	$1,734
Mupirocin	45	$400
Triamcinolone Acetonide	17	$177
Ketoconazole	11	$129
Cephalexin	13	$64
Tramadol Hcl	11	$17

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Valencia

Sarah ArronBurlingame$98K
Daniel Zelacla Jolla$43K
Ralph MasseySanta Monica$38K
Michael MortazieOrange$29K
Sumaira AasiStanford$27K
Andrea WilleySacramento$21K
Benjamin Kelleyla Jolla$20K
Frank NoodlemanSaratoga$19K
Howard FeinRolling Hills Estates$19K
Joanna ChanLong Beach$18K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →